Table 2: Clinical and laboratory findings in studied SLE population.
| Items | No | % |
|---|---|---|
| Mucocutanous manifestations | ||
| Malar rash | 54 | 91.5 |
| Discoid rash | 12 | 20.3 |
| Photosensitivity | 49 | 83.1 |
| Oral ulcers | 50 | 84.7 |
| Arthritis | 31 | 52.5 |
| Serositis (pleurisy, pericardium rub) | 26 | 44.1 |
| Renal findings | ||
| Non | 7 | 11..9 |
| Persistent proteinuria >0.5 grams/day or greater than 3+ | 6 | 10.2 |
| Cellular casts | 14 | 23.7 |
| Both | 32 | 54.2 |
| Neuropsychiatric manifestations | ||
| Non | 41 | 69.5 |
| Seizures | 10 | 16.9 |
| Psychosis | 1 | 1.7 |
| Persistence unexplained headache | 7 | 11.9 |
| Hematological manifestations | ||
| No | 3 | 5.1 |
| Anemia | 30 | 50.8 |
| Leucopenia (<4000/mm) | 33 | 55.9 |
| Lymphopenia (<1500/mm) | 3 | 5.1 |
| Thrombocytopenia (<100.000/mm) | 20 | 33.9 |
| Anti-DNA & anti-phospholipids Abs negative | 12 | 20.3 |
| Anti-DNA Abs positive | 42 | 73.9 |
| Anti-DNA & anti-phospholipids Abs positive | 4 | 6.8 |
| ANA positive | 59 | 100 |